🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Bone Marrow Failure Syndromes

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TruSight Oncology, imatinib CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia NCT06633328EARLY Phase 11 site📍 Hanzhou Zhejiang University · Tests: CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation Reproductive and Mental Health of Patients With Aplastic Anemia NCT06936930n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Sex hormone monitoring A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites📍 Birmingham📍 Gilbert📍 Phoenix Center for International Blood and Marrow Transplant Resear… · Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data NCT07877727n/a4 sites📍 Avellino📍 Genova📍 Naples Istituto Giannina Gaslini Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome NCT01624805Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, Methylprednisolone, Pegfilgrastim Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa Adverse Effects of ATG/ALG Therapy in Aplastic Anemia NCT07461116n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: ATG/ALG Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years NCT06646497Phase 226 sites📍 Paris📍 Amiens📍 Angers Assistance Publique - Hôpitaux de Paris · Tests: Allogeneic hematopoietic stem cell transplantation Stem cell source only Bone Marrow Revolade Tablets Specified Drug-use Survey NCT06287268n/a17 sites📍 Nagoya📍 Nagoya📍 Toyoake Novartis Pharmaceuticals · Tests: eltrombopag CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases NCT06787560EARLY Phase 11 site📍 Hangzhou Zhejiang University · Tests: CD7 CAR-T cells injection, Allo-HSCT European Rare Blood Disorders Platform (ENROL) NCT06250595n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Collection of clinical and laboratory data from EHR. Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders NCT07585136Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Filgrastim, Plerixafor, Leukapheresis Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS NCT07578675n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms NCT06303193Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: pacritinib Nucleoside Therapy in Patients With Telomere Biology Disorders NCT06817590Phase 11 site📍 Boston Suneet Agarwal · Tests: deoxycytidine, deoxythymidine High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) NCT07205523n/a1 site📍 Xining Yigeng Cao,MD,PhD Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform NCT06999954n/a1 site📍 Woburn Shwachman-Diamond Syndrome Alliance Inc Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia NCT07714512Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Isatuximab Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia NCT05687149n/a1 site📍 Bethesda National Cancer Institute (NCI) CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia NCT06622694Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: RD13-02 Haploidentical HCT for Severe Aplastic Anemia NCT04558736Phase 21 site📍 Memphis St. Jude Children's Research Hospital · Tests: Anti-Thymocyte Globulin (Rabbit), Fludarabine, Cyclophosphamide, Mesna, G-CSF Natural History of Acquired and Inherited Bone Marrow Failure Syndromes NCT05012111n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia NCT07901959Phase 12 sites📍 Minneapolis📍 New York Rockefeller University · Tests: Metformin, Naproxen Sodium A Study of Emapalumab for Pediatric Aplastic Anemia NCT06430788Phase 26 sites📍 New York📍 Cincinnati📍 Philadelphia Memorial Sloan Kettering Cancer Center · Tests: Emapalumab Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) NCT07186179n/a1 site📍 New Hyde Park Northwell Health · Tests: Mobilization Regimen AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion NCT04099966Phase 21 site📍 Valhalla Mitchell Cairo · Tests: alpha beta depletion Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study NCT06650553NA1 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT … Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy